Micah Belzberg1, Smruti Mahapatra2, Alexander Perdomo-Pantoja3, Francisco Chavez4, Kyle Morrison4, Kah Timothy Xiong4, Nao J Gamo5, Stephen Restaino5, Nitish Thakor2, Youseph Yazdi2, Rajiv Iyer3, Betty Tyler3, Nicholas Theodore6, Mark G Luciano6, Henry Brem6, Mari Groves3, Alan R Cohen3, Amir Manbachi7. 1. Department of Dermatology, Johns Hopkins University, Baltimore, MD, USA. 2. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. 3. Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, USA. 4. Sonic Concepts, Inc., Bothell, WA, USA. 5. Maryland Development Center, Baltimore, MD, USA. 6. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, USA. 7. Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, USA. Electronic address: Amir.Manbachi@jhu.edu.
Abstract
INTRODUCTION: To improve patient outcomes (eg, reducing blood loss and infection), practitioners have gravitated toward noninvasive and minimally invasive surgeries (MIS), which demand specialized toolkits. Focused ultrasound, for example, facilitates thermal ablation from a distance, thereby reducing injury to surrounding tissue. Focused ultrasound can often be performed noninvasively; however, it is more difficult to carry out in neuro-oncological tumors, as ultrasound is dramatically attenuated while propagating through the skull. This shortcoming has prompted exploration of MIS options for intracranial placement of focused ultrasound probes, such as within the BrainPath™ (NICO Corporation, Indianapolis, IN). Herein, we present the design, development, and in vitro testing of an image-guided, focused ultrasound prototype designed for use in MIS procedures. This probe can ablate neuro-oncological lesions despite its small size. MATERIALS & METHODS: Preliminary prototypes were iteratively designed, built, and tested. The final prototype consisted of three 8-mm-diameter therapeutic elements guided by an imaging probe. Probe functionality was validated on a series of tissue-mimicking phantoms. RESULTS: Lesions were created in tissue-mimicking phantoms with average dimensions of 2.5 × 1.2 × 6.5 mm and 3.4 × 3.25 × 9.36 mm after 10- and 30-second sonification, respectively. 30 s sonification with 118 W power at 50% duty cycle generated a peak temperature of 68 °C. Each ablation was visualized in real time by the built-in imaging probe. CONCLUSION: We developed and validated an ultrasound-guided focused ultrasound probe for use in MIS procedures. The dimensional constraints of the prototype were designed to reflect those of BrainPath trocars, which are MIS tools used to create atraumatic access to deep-seated brain pathologies.
INTRODUCTION: To improve patient outcomes (eg, reducing blood loss and infection), practitioners have gravitated toward noninvasive and minimally invasive surgeries (MIS), which demand specialized toolkits. Focused ultrasound, for example, facilitates thermal ablation from a distance, thereby reducing injury to surrounding tissue. Focused ultrasound can often be performed noninvasively; however, it is more difficult to carry out in neuro-oncological tumors, as ultrasound is dramatically attenuated while propagating through the skull. This shortcoming has prompted exploration of MIS options for intracranial placement of focused ultrasound probes, such as within the BrainPath™ (NICO Corporation, Indianapolis, IN). Herein, we present the design, development, and in vitro testing of an image-guided, focused ultrasound prototype designed for use in MIS procedures. This probe can ablate neuro-oncological lesions despite its small size. MATERIALS & METHODS: Preliminary prototypes were iteratively designed, built, and tested. The final prototype consisted of three 8-mm-diameter therapeutic elements guided by an imaging probe. Probe functionality was validated on a series of tissue-mimicking phantoms. RESULTS: Lesions were created in tissue-mimicking phantoms with average dimensions of 2.5 × 1.2 × 6.5 mm and 3.4 × 3.25 × 9.36 mm after 10- and 30-second sonification, respectively. 30 s sonification with 118 W power at 50% duty cycle generated a peak temperature of 68 °C. Each ablation was visualized in real time by the built-in imaging probe. CONCLUSION: We developed and validated an ultrasound-guided focused ultrasound probe for use in MIS procedures. The dimensional constraints of the prototype were designed to reflect those of BrainPath trocars, which are MIS tools used to create atraumatic access to deep-seated brain pathologies.
Authors: M Marinova; H M Strunk; M Rauch; J Henseler; T Clarens; L Brüx; R Dolscheid-Pommerich; R Conrad; H Cuhls; L Radbruch; H H Schild; M Mücke Journal: Schmerz Date: 2017-02 Impact factor: 1.107
Authors: Eric S Sussman; Christopher P Kellner; Eric Nelson; Michael M McDowell; Samuel S Bruce; Rachel A Bruce; Zong Zhuang; E Sander Connolly Journal: J Neurosurg Date: 2014-01-10 Impact factor: 5.115
Authors: David S Hersh; Anthony J Kim; Jeffrey A Winkles; Howard M Eisenberg; Graeme F Woodworth; Victor Frenkel Journal: Neurosurgery Date: 2016-11 Impact factor: 4.654
Authors: Elodie Constanciel; W Apoutou N'Djin; Francis Bessière; Françoise Chavrier; Daniel Grinberg; Alexandre Vignot; Philippe Chevalier; Jean Yves Chapelon; Cyril Lafon Journal: IEEE Trans Ultrason Ferroelectr Freq Control Date: 2013-09 Impact factor: 2.725
Authors: G Malietzis; L Monzon; J Hand; H Wasan; E Leen; M Abel; A Muhammad; P Price; P Abel Journal: Br J Radiol Date: 2013-02-12 Impact factor: 3.039
Authors: Graham C Collins; Achraj Sarma; Zachary L Bercu; Jaydev P Desai; Brooks D Lindsey Journal: IEEE Trans Biomed Eng Date: 2021-06-17 Impact factor: 4.756